| Similar Articles |
|---|
 |
Scientific American
June 2008
Melinda Wenner |
Jeremy Nicholson's Gut Instincts: Researching Intestinal Bacteria The body and its intestinal flora produce chemicals with hidden health information, Jeremy Nicholson has found. Someday treating disease may mean treating those bacteria.   |
Chemistry World
April 11, 2007
Victoria Gill |
A Dog's Life A group of dogs that enjoyed long lives on carefully planned diets has provided researchers with a unique life-long metabolic profile. The data reveal the relationship between diet, disease and longevity. |
Scientific American
November 14, 2005
Gunjan Sinha |
Bugs and Drugs Gut bacteria could determine how well medicines work. |
Chemistry World
July 2010
Anna Lewcock |
Medicine made to measure Healthcare tailored to suit the genetic makeup of the patient is finally coming to fruition. |
Bio-IT World
July 14, 2004
Karen Hopkin |
'Omics: The NextGeneration Researchers in industry and academia are cataloging collections of biochemical compounds (metabolomics) to determine how they respond when organisms are challenged by drugs, disease, or stress (metabonomics). |
Bio-IT World
April 2007
Kevin Davies |
The Human Metabolome Project Motivated by the absence of a metabolomic equivalent of GenBank that could provide information and possibly even samples of metabolites, researchers secured $7.5 million funding from Genome Canada in 2005 for the "Human Metabolome Project." |
Chemistry World
August 1, 2012
Patrick Walter |
Phenomenal Olympic science legacy (or is that sustainability?) What do you do with a lab set up solely to catch Olympic drug cheats once the games are over? In the case of the London 2012 games, the answer is to turn it into a state of the art analytical lab. |
HHMI Bulletin
Aug 2010
Sarah C.P. Williams |
Gut Bacteria Do More Than Digest Food Someone can blame their diabetes or inflammatory bowel disease on the churning mass of bacteria that lives inside their intestines, but there's no magic pill to change the dynamics of that complicated world of the human microbiome. |
Scientific American
February 28, 2005
Gunjan Sinha |
The Diet That Fits With the understanding that some diseases such as obesity are metabolic syndromes in which multiple biochemical pathways interact to cause complex symptoms, metabolic testing offers a way to gauge health over a lifetime. |
Pharmaceutical Executive
September 1, 2005
Mattingly & Saxberg |
Biomarkers Come of Age In the past five years, biomarkers have become an essential part of pharmaceutical R&D. Seven industry experts explain how it happened - and what comes next. |
Chemistry World
May 22, 2007
James Mitchell Crow |
Scientists Seek Indicators of Illness A 17 million-pound fund has been set up by the UK's Medical Research Council for research into biomarkers, the tell-tale body chemicals that are associated with particular diseases. |
Pharmaceutical Executive
November 1, 2011
Elizabeth O. Coulton |
Clinical Trial Issues Not Just Black and White The selection of clinical trial participants must meld with the changing demographics of America if industry is to improve medicines that work for patients. |
Chemistry World
March 7, 2011
Russell Johnson |
Breathe out for personalised medicine A method to analyse drug levels in the body could allow people with epilepsy to avoid weeks of blood tests, claim scientists from Switzerland. |
Chemistry World
March 20, 2011
Simon Hadlington |
Amino acids flag risk of diabetes Raised levels of certain amino acids in the blood could flag up the possibility of someone developing diabetes later in life, researchers in the US have discovered. |
BusinessWeek
June 13, 2005
John Carey |
The NIH's Roadmap for Research Charting the human genome was just the beginning. Now the focus is creating pathways that will lead to practical applications. |
Chemistry World
November 2, 2015
Charlie Quigg |
Biomarkers identify stroke victims with cognitive problems Scientists in China have pinpointed three metabolites that indicate if a stroke victim has suffered cognitive damage. |
Chemistry World
December 16, 2013
Michael Parkin |
1024 samples analysed on a single chip Researchers in Switzerland have developed a microfluidic platform able to measure four protein biomarkers in over 1000 blood samples on a single microfluidic chip. |
Reactive Reports
October 2007
David Bradley |
Chocoholics Anonymous Scientific research funded by chocolate makers at Nestle has demonstrated a link between our love of chocolate and a specific chemical signature programmed into our metabolism. |
Chemistry World
January 15, 2014
Kirsty Muirhead |
Biomarkers leave gender clues at crime scene Scientists in the US have unveiled details of a colorimetric assay that could provide an initial indication of a suspect's gender during the on-scene stages of a forensic investigation. |
Fast Company
February 2015
Jon Gertner |
What's Lurking In Your Microbiome? Possibly, a Cure for Disease Second Genome is a small company that focuses on the microbiome: the trillions of bacteria, viruses, and fungi that people carry around with them from birth until death. |
Bio-IT World
April 2007
Malorye Allison |
Biomarkers versus Blockbusters Are companies really changing their strategies and using biomarkers to target smaller, better defined patient sets with their new drugs? Or is the vast majority of pharma biomarker studies just aimed at culling bad drugs from their pipelines? |
Chemistry World
January 27, 2011
Elinor Richards |
Diet affects cholesterol drug Copper and zinc in the diet could impair the action of statin drugs, compounds prescribed to lower cholesterol, say US scientists. |
AskMen.com
February 27, 2014
Patrick Owen |
They've Discovered Something That Might Cure Obesity. But It's Seriously Gross. The eternal battle between good and bad bacteria in your gut is greatly affected by your diet, sleep, stress levels, and general health. |
Chemistry World
May 13, 2011
James Urquhart |
Synthetic cannabis drug test US researchers have developed a new urine test for detecting and quantifying some of the metabolites associated with synthetic cannabis. |
Chemistry World
December 22, 2006
Victoria Gill |
Metabolic Profiling Could Improve Animal Experiments Different types of rats respond to drugs in substantially different ways that can be tracked by metabolic analysis, according to scientists who say their finding has major implications for designing animal experiments. |
Bio-IT World
April 15, 2003
Malorye Branca |
Beyond the Blueprint How will the wealth of data emanating from the human genome and allied technologies impact research on health and disease? |
Managed Care
February 2008
Thomas Morrow |
As the Use of Biomarkers Grows, Managed Care Companies Will Face Tough Decisions About Setting Limits Health care faces difficult challenges as it increasingly incorporates a personalized approach that uses various biomarkers to influence medical decision-making. |
Chemistry World
September 5, 2013
Jason Woolford |
A biochemical eyewitness Blood found at a crime scene could give police an indication of a criminal suspect's ethnicity there and then thanks to a new bioassay. |
Wired
October 2006
Thomas Goetz |
The Thin Pill 75 million Americans may have something called metabolic syndrome. How Big Pharma turned obesity into a disease - then invented the drugs to cure it. |
Chemistry World
November 8, 2006
Victoria Gill |
Molecular Signals of Schizophrenia Identified Researchers have identified specific biomarkers for schizophrenia, a discovery which could pave the way to more accurate diagnostics, improved treatments, and could even be the starting point for the development of preventative medicines. |
Bio-IT World
March 8, 2005
Patricia Reilly |
Biomarkers: Trends and Potential Companies are centralizing biomarker research to help reduce spending. |
Bio-IT World
April 16, 2004 |
Portraits in Proteomics Advances in identifying protein biomarkers are spurring new hope in cancer diagnostics, expediting detection and easing testing. |
Bio-IT World
May 2006 |
News Blast Aids Action... Oxford Universal... Myriad Options... |
Bio-IT World
March 2006
John Russell |
It's All About the Drugs A conversation with biopharma Organon's executive VP for global research and development highlights how, regardless of the company's enthusiasm for new technology, it is first and foremost interested in pharmacology and medicinal chemistry -- drugs. |
Nursing
September 2010
Margaret M. Bolton |
Sounding the alarm about metabolic syndrome Any health problem that affects a third of American adults is sure to impact your nursing practice. Metabolic syndrome, a growing and commonly silent condition, poses a significant public health crisis. |
Scientific American
June 2006
Philip Yam |
The Ultimate Blood Test A pricey way to determine health risks: the Biophysical 250 assessment, a series of 250 blood tests done at one time. |
Pharmaceutical Executive
January 1, 2006
Clinton & Wechsler |
What Ever Happened to Critical Path FDA's ambitious program to improve drug development disappeared from view almost as soon as it was announced. Suddenly, it's back, but is it here to stay? |
